Lina Kang

1.8k citations
54 papers · 1.4k indexed · h-index 21
Topics
Angiogenesis and VEGF in Cancer (9 papers)Cardiac Fibrosis and Remodeling (9 papers)Extracellular vesicles in disease (8 papers)

In The Last Decade

Lina Kang

53 papers receiving 1.4k citations

Peers

Lina Kang
Comparison fields: 5 of 98
  • Molecular Biology 673
  • Cardiology and Cardiovascular Medicine 355
  • Surgery 281
  • Endocrinology, Diabetes and Metabolism 203
  • Cancer Research 203
Replace Yasutomo Fukunaga with:
Yasutomo Fukunaga Japan
Souad Belmadani United States
Scott P. Levick United States
Alicia N. Lyle United States
Genshan Ma China
Mauro Torti Italy
Weiwei Qi China
Wenjun Yan China
Simon Tual‐Chalot United Kingdom
Séréna Grimaldi Italy
Lina Kang relative to Yasutomo Fukunaga Japan Yasutomo Fukunaga's profile →
Citations per field
00.5×10×15.4×
Yasutomo Fukunaga · 1×
Citations per year

Countries citing papers authored by Lina Kang

Since Specialization
Citations

This map shows the geographic impact of Lina Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Kang more than expected).

Fields of papers citing papers by Lina Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Kang. The network helps show where Lina Kang may publish in the future.

Co-authorship network of co-authors of Lina Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Kang. A scholar is included among the top collaborators of Lina Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Kang. Lina Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 2
3 0
4 5
5 23
6 11
7 18
8 15
9 5
10 20
11 33
12 1
13 30
14 37
15 4
16 108
17
[Overexpression of integrin-linked kinase improves cardiac function in a rat model of doxorubicin-induced chronic heart failure].
2
18 35
19 67
20 85

About Lina Kang

Lina Kang is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Cancer Research, having authored 54 papers that have together received 1.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Cardiac Fibrosis and Remodeling (9 papers) and Extracellular vesicles in disease (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (355 citations), Cancer Research (203 citations) and Genetics (132 citations). Lina Kang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Biao Xu, Yihai Liu, Mingyue Wu, Zhonghai Wei, Biao Xu, Jun Xie, Qin Chen, Jinxuan Zhao, Qiaoling Li and Rong Gu. Their work appears in journals such as ACS Nano, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026